N E W S B Y T E S
The currently approved vaccines used as booster doses are designed against the ancestral strain of SARS-CoV-2 . Although these will increase the antibody titers , their ability to neutralize the circulating Omicron variant of SARS-CoV-2 is limited . Developing antibodies and memory immune responses specific to the Omicron variant would reduce the probability of infection and hospitalization . The Made-in-India GEMCOVAC ® -OM specifically addresses this gap .
Leucine Rich Bio forays into US , establishes Crown Biome as an oral microbiome company
Leucine Rich Bio , South Asia ’ s leading microbiome company , is all set to foray into US healthcare with the establishment of Crown Biome Inc , a visionary US-based entity dedicated to revolutionizing oral healthcare through
cutting-edge products and solutions . Crown Biome Inc will be helmed by its CEO Bryan Toton . The oral microbiome refers to the collective genome of the microbes that are present in a person ’ s mouth . An increasing number of studies demonstrate a close link between chronic diseases and an imbalance in the microbiome .
Kumar Sankaran , Founder and CEO of Leucine Rich Bio expressed his excitement about the establishment of Crown Biome Inc and the potential it holds for transforming the industry . He stated , “ We are thrilled to unveil Crown Biome Inc , a venture that
represents years of dedication and passion . Our team ’ s relentless pursuit of innovation has brought us to this remarkable juncture . Crown Biome ’ s focus on the oral microbiome will revolutionize dentistry and pave the way for a new era of comprehensive healthcare .”
10
BioVoiceNews | July 2023